Showing results (301-310 of 382) with videos related to

Sort By:
Pageof 39
Prostate Cancer and Prostatic Diseases|March 21, 2018
Combining immune check-point blockade and cryoablation in an immunocompetent hormone sensitive murine model of prostate cancerBenjamin Benzon, Stephanie A Glavaris, Brian W Simons, et al.
European Urology Oncology|May 29, 2021
Neoadjuvant Nivolumab in Patients with High-risk Nonmetastatic Renal Cell CarcinomaMichael A Gorin, Hiten D Patel, Steven P Rowe, et al.
The Lancet. Oncology|October 13, 2012
Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage studyDavid Olmos, Daniel Brewer, Jeremy Clark, et al.
NPJ Genomic Medicine|January 22, 2024
Divergent immune microenvironments in two tumor nodules from a patient with mismatch repair-deficient prostate cancerHannah E Bergom, Laura A Sena, Abderrahman Day, et al.
The American Journal of Surgical Pathology|August 18, 2017
Cutaneous Eruptions in Patients Receiving Immune Checkpoint Blockade: Clinicopathologic Analysis of the Nonlichenoid Histologic PatternGenevieve J Kaunitz, Manisha Loss, Hira Rizvi, et al.
Cancer Immunology Research|October 4, 2017
Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor MicroenvironmentYuki Muroyama, Thomas R Nirschl, Christina M Kochel, et al.
Journal for Immunotherapy of Cancer|July 1, 2021
TGM4: an immunogenic prostate-restricted antigenZoila A Lopez-Bujanda, Aleksandar Obradovic, Thomas R Nirschl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2015
Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical OutcomeDebraj GuhaThakurta, Nadeem A Sheikh, Li-Qun Fan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 31, 2015
Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention TrialTeemu J Murtola, Bora Gurel, Martin Umbehr, et al.
Pageof 39